Gabapentin Dementia Lawsuit in Illinois - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Illinois is a critical jurisdiction for gabapentin cognitive decline litigation due to its experienced plaintiff bar, sophisticated mass tort judges, and Cook County's historically plaintiff-favorable venue reputation. The Northern District of Illinois (Chicago) has managed major pharmaceutical MDLs and is a strong candidate for gabapentin MDL assignment if consolidation is sought. Illinois's large population of 12.6 million generates substantial gabapentin prescribing volumes, with the highest per-capita rates in downstate communities affected by the opioid crisis and industrial chronic pain. The state's major academic medical centers — Northwestern, University of Chicago, Rush, and Loyola — provide comprehensive neurology and neuropsychology resources for diagnosing gabapentin-induced cognitive decline. Illinois eliminated statutory damage caps when the state Supreme Court struck them down, making it one of the most favorable jurisdictions for pharmaceutical injury plaintiffs.

Written By

People's Justice Legal Research Team

Statute of Limitations

Illinois: 2 years for personal injury (735 ILCS 5/13-202). Discovery rule applies — limitations begin when the plaintiff discovers or should have discovered the injury and its connection to gabapentin.

2 years from discovery of injury

Filing Venue

Where to File in Illinois

Illinois gabapentin cases may be filed in the Northern District (Chicago), Central District (Springfield), or Southern District (East St. Louis). The Northern District has a dedicated complex litigation program and MDL experience. Cook County Circuit Court is one of the most plaintiff-favorable state court venues nationally. Illinois eliminated tort reform damage caps in Lebron v. Gottlieb Memorial Hospital (2010), meaning no statutory caps on compensatory or punitive damages exist in product liability cases. The state follows modified comparative fault with a 50% bar.

Illinois Data

Exposure in Illinois

Source: IQVIA / IL PDMP data

Source: Lebron v. Gottlieb Memorial Hospital, 930 N.E.2d 895 (Ill. 2010)

Source: Northwestern Medicine / UChicago Medicine

FAQ

Frequently Asked Questions

See details below.

Back to Gabapentin Dementia Lawsuit Lawsuit Overview